Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ziprasidone for Metabolic Syndrome Risk in Bipolar Disorder
NCT01113541Phase 3Terminated
- Sponsor
- Viatris
- Start
- Jul 2010
- Primary completion
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ziprasidone in bipolar disorder (BD), sponsored by Viatris. Started Jul 2010; status: terminated.
02
Drugs
ziprasidone
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT01113541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01113541.